Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK and PD of Trazpiroben (TAK-906) in Gastroparesis
NCT03268941Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Sep 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trazpiroben in gastroparesis, sponsored by Millennium Pharmaceuticals. Started Sep 2017; status: completed.
02
Drugs
trazpiroben
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT03268941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03268941.